Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 101

1.

Efficacy and safety of a novel ĸ-agonist for managing intractable pruritus in dialysis patients.

Kumagai H, Ebata T, Takamori K, Miyasato K, Muramatsu T, Nakamoto H, Kurihara M, Yanagita T, Suzuki H.

Am J Nephrol. 2012;36(2):175-83. doi: 10.1159/000341268. Epub 2012 Aug 3.

PMID:
22868684
[PubMed - indexed for MEDLINE]
Free Article
2.

Effect of a novel kappa-receptor agonist, nalfurafine hydrochloride, on severe itch in 337 haemodialysis patients: a Phase III, randomized, double-blind, placebo-controlled study.

Kumagai H, Ebata T, Takamori K, Muramatsu T, Nakamoto H, Suzuki H.

Nephrol Dial Transplant. 2010 Apr;25(4):1251-7. doi: 10.1093/ndt/gfp588. Epub 2009 Nov 19.

PMID:
19926718
[PubMed - indexed for MEDLINE]
Free Article
3.

Nalfurafine hydrochloride: a new drug for the treatment of uremic pruritus in hemodialysis patients.

Nakao K, Mochizuki H.

Drugs Today (Barc). 2009 May;45(5):323-9. doi: 10.1358/dot.2009.45.5.1362067. Review.

PMID:
19584962
[PubMed - indexed for MEDLINE]
4.

[Pharmacological and clinical profiles of nalfurafine hydrochloride (Remitch) capsules 2.5 microg) , a new therapeutic agent for the treatment of uremic pruritus in hemodialysis patients].

Nakao K, Ando A, Hirakata M, Ando N, Takeshita K, Miyamoto Y, Mochizuki H.

Nihon Yakurigaku Zasshi. 2010 May;135(5):205-14. Review. Japanese. No abstract available.

PMID:
20467170
[PubMed - indexed for MEDLINE]
5.

Kappa-opioid system in uremic pruritus: multicenter, randomized, double-blind, placebo-controlled clinical studies.

Wikström B, Gellert R, Ladefoged SD, Danda Y, Akai M, Ide K, Ogasawara M, Kawashima Y, Ueno K, Mori A, Ueno Y.

J Am Soc Nephrol. 2005 Dec;16(12):3742-7. Epub 2005 Oct 26.

PMID:
16251241
[PubMed - indexed for MEDLINE]
Free Article
6.

Nalfurafine hydrochloride for the treatment of pruritus.

Inui S.

Expert Opin Pharmacother. 2012 Jul;13(10):1507-13. doi: 10.1517/14656566.2012.693164. Epub 2012 Jun 5. Review.

PMID:
22663138
[PubMed - indexed for MEDLINE]
7.

One year long-term study on abuse liability of nalfurafine in hemodialysis patients.

Ueno Y, Mori A, Yanagita T.

Int J Clin Pharmacol Ther. 2013 Nov;51(11):823-31. doi: 10.5414/CP201852.

PMID:
24040851
[PubMed - indexed for MEDLINE]
8.

Spontaneous scratching behavior in MRL/lpr mice, a possible model for pruritus in autoimmune diseases, and antipruritic activity of a novel kappa-opioid receptor agonist nalfurafine hydrochloride.

Umeuchi H, Kawashima Y, Aoki CA, Kurokawa T, Nakao K, Itoh M, Kikuchi K, Kato T, Okano K, Gershwin ME, Miyakawa H.

Eur J Pharmacol. 2005 Aug 22;518(2-3):133-9.

PMID:
16055114
[PubMed - indexed for MEDLINE]
9.

Systemic kappa opioid receptor agonists in the treatment of chronic pruritus: a literature review.

Phan NQ, Lotts T, Antal A, Bernhard JD, Ständer S.

Acta Derm Venereol. 2012 Sep;92(5):555-60. doi: 10.2340/00015555-1353. Review.

PMID:
22504709
[PubMed - indexed for MEDLINE]
Free Article
10.

A randomized, placebo-controlled, double-blind trial of ondansetron in renal itch.

Murphy M, Reaich D, Pai P, Finn P, Carmichael AJ.

Br J Dermatol. 2003 Feb;148(2):314-7.

PMID:
12588385
[PubMed - indexed for MEDLINE]
11.

Nalfurafine, a kappa opioid receptor agonist, inhibits scratching behavior secondary to cholestasis induced by chronic ethynylestradiol injections in rats.

Inan S, Cowan A.

Pharmacol Biochem Behav. 2006 Sep;85(1):39-43. Epub 2006 Aug 17.

PMID:
16919318
[PubMed - indexed for MEDLINE]
12.

A pramoxine-based anti-itch lotion is more effective than a control lotion for the treatment of uremic pruritus in adult hemodialysis patients.

Young TA, Patel TS, Camacho F, Clark A, Freedman BI, Kaur M, Fountain J, Williams LL, Yosipovitch G, Fleischer AB Jr.

J Dermatolog Treat. 2009;20(2):76-81. doi: 10.1080/09546630802441218.

PMID:
18821119
[PubMed - indexed for MEDLINE]
13.

[Pharmacological effects of nalfurafine hydrochloride, a kappa-opioid receptor agonist].

Nakao K, Hasebe K, Yoshikawa S, Ikeda K, Hirakata M, Miyamoto Y, Mochizuki H.

Nihon Shinkei Seishin Yakurigaku Zasshi. 2010 Nov;30(5-6):185-91. Review. Japanese.

PMID:
21226314
[PubMed - indexed for MEDLINE]
14.

Efficacy and safety of a new kappa-opioid receptor agonist for the treatment of uremic pruritus.

Delmez JA.

Nat Clin Pract Nephrol. 2006 Jul;2(7):358-9. No abstract available.

PMID:
16932462
[PubMed - indexed for MEDLINE]
15.

Molecule of the Month. Nalfurafine hydrochloride.

[No authors listed]

Drug News Perspect. 2009 Dec;22(10):619. No abstract available.

PMID:
20140281
[PubMed - indexed for MEDLINE]
16.

Naltrexone does not relieve uremic pruritus: results of a randomized, double-blind, placebo-controlled crossover study.

Pauli-Magnus C, Mikus G, Alscher DM, Kirschner T, Nagel W, Gugeler N, Risler T, Berger ED, Kuhlmann U, Mettang T.

J Am Soc Nephrol. 2000 Mar;11(3):514-9.

PMID:
10703675
[PubMed - indexed for MEDLINE]
Free Article
17.

Effect of nalfurafine hydrochloride on pruritus and anxiety level in hemodialysis patients.

Inui S, Shirakawa Y, Itami S.

J Dermatol. 2012 Oct;39(10):886-7. doi: 10.1111/j.1346-8138.2011.01442.x. Epub 2011 Dec 5. No abstract available.

PMID:
22142516
[PubMed - indexed for MEDLINE]
18.

Sericin cream reduces pruritus in hemodialysis patients: a randomized, double-blind, placebo-controlled experimental study.

Aramwit P, Keongamaroon O, Siritientong T, Bang N, Supasyndh O.

BMC Nephrol. 2012 Sep 24;13:119. doi: 10.1186/1471-2369-13-119.

PMID:
23006933
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Low-dose doxepin for treatment of pruritus in patients on hemodialysis.

Pour-Reza-Gholi F, Nasrollahi A, Firouzan A, Nasli Esfahani E, Farrokhi F.

Iran J Kidney Dis. 2007 Jul;1(1):34-7.

PMID:
19357442
[PubMed - indexed for MEDLINE]
Free Article
20.

Efficacy and safety of oral naltrexone treatment for pruritus of cholestasis, a crossover, double blind, placebo-controlled study.

Terg R, Coronel E, Sordá J, Muñoz AE, Findor J.

J Hepatol. 2002 Dec;37(6):717-22.

PMID:
12445410
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk